Correction: Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling
Yingyan Wang, Wen Lan, Mingxin Xu, Jing Song, Jun Mao, Chunyan Li, Xiaohui Du, Yunling Jiang, Encheng Li, Rui Zhang, Qi Wang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPulmonary Hypertension Research and Treatments · RNA modifications and cancer · Cancer Diagnosis and Treatment
Correction to: Cell Death and Disease 10.1038/s41419-021-03509-x, published online 26 February 2021
In this article Fig. 6C showed a lot of band results of Western blotting assays, that have been mistakenly re-used in the GAPDH band of the A549 group as an internal reference Histone for SPCA-1 nuclear proteins and further quantified the relative levels of β-catenin.
Different internal references may lead to different analysis results. So, we traced back the original bands and found the results of three independent replicate experiments performed to detect the expression of β-catenin and corresponding Histone after nuclear protein extraction in SPCA-1 cells. The relative levels of β-catenin were also re-quantified.
Fortunately, this correction did not affect the statistical differences in the levels of β-catenin between groups.
Correct Fig. 6
Incorrect Fig. 6
The original article has been corrected.